Difference between revisions of "Zoledronic acid (Zometa)"
Jump to navigation
Jump to search
(Created page with "http://www.pharma.us.novartis.com/product/pi/pdf/Zometa.pdf ==General information== Class: Bisphosphonate, inhibits osteoclast activity and bone resorption/turnover, induces ost...") |
m |
||
| Line 1: | Line 1: | ||
| − | |||
| − | |||
==General information== | ==General information== | ||
Class: Bisphosphonate, inhibits osteoclast activity and bone resorption/turnover, induces osteoclast apoptosis<ref name="insert">[http://www.pharma.us.novartis.com/product/pi/pdf/Zometa.pdf Zoledronic acid (Zometa) package insert]</ref><ref>[http://hemonc.org/docs/chemotherapypackageinsert/zoledronicacid.pdf Zoledronic acid (Zometa) package insert (locally hosted backup)]</ref> | Class: Bisphosphonate, inhibits osteoclast activity and bone resorption/turnover, induces osteoclast apoptosis<ref name="insert">[http://www.pharma.us.novartis.com/product/pi/pdf/Zometa.pdf Zoledronic acid (Zometa) package insert]</ref><ref>[http://hemonc.org/docs/chemotherapypackageinsert/zoledronicacid.pdf Zoledronic acid (Zometa) package insert (locally hosted backup)]</ref> | ||
Revision as of 03:19, 17 November 2011
General information
Class: Bisphosphonate, inhibits osteoclast activity and bone resorption/turnover, induces osteoclast apoptosis[1][2]
Route: IV
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the package insert[1].